/Companies

Atraverse Medical

Chicago, US · Founded 2022 · Delaware corporation · 36 employees on LinkedIn · 2 known investors

Find your way into Atraverse Medical

Each arrow is one introduction. Sign up to fill in the first one.

106 people can intro you to Steven

Ask Michael Wiley to introduce you to Steven Mickelsen

You →Michael · together at FARAPULSE, Inc. →Steven

38 people can intro you to John

Ask Jamie Chen to introduce you to John R Slump

You →Jamie · together at FARAPULSE, Inc. →John

Sign up to find every way you can get introduced to Atraverse Medical

  • Your email: who you already know at Atraverse Medical, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Atraverse Medical team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Atraverse Medical develops flexible transseptal access technologies for left-heart catheter procedures, including an RF-guidewire enabled puncture device that supports a Zero Exchange workflow. Its products are aimed at physicians performing catheter-based cardiac interventions.

Founders & leadership

Atraverse Medical was founded in 2022 by Steven Mickelsen.

SMSteven Mickelsen
Steven MickelsenFounder · Board MemberSteven Mickelsen is Director at Atraverse Medical, where he works on transseptal access technologies for cardiac catheterization procedures. He has focused on developing medical devices for heart rhythm and cardiovascular conditions, with experience spanning preclinical development and clinical cardiology.
JRJohn R Slump
John R SlumpCEO/President & Co-Founder2022–2026John R Slump is an executive and director at Atraverse Medical, which develops flexible transseptal access technologies for left-heart catheter procedures. He has held leadership roles at multiple medical device companies including those later acquired by Integra, Haemonetics, and Boston Scientific.

Board

ES
Eric SauterBoard director

Investors · 2

Reported raises · per SEC filings

Form D private placements

$33.1M disclosed across 5 rounds · 2023–2025

▶$8.6MraisedMay 2025 · 41 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Eric D. SauterExecutive Officer, Director, Promoter
  • John R. SlumpExecutive Officer, Director, Promoter
  • Steven MickelsenExecutive Officer, Director, Promoter
Offering amount
$10M
Amount sold
$8.6M
First sale
Apr 2025
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MraisedFeb 2025 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Eric D. SauterExecutive Officer, Director, Promoter
  • John R SlumpExecutive Officer, Director, Promoter
  • Steven R. MickelsenExecutive Officer, Director, Promoter
Offering amount
$15M
Amount sold
$15M
First sale
Feb 2025
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.1MraisedAug 2024 · 33 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Eric SauterDirector
  • Steven MickelsenDirector
  • John R SlumpExecutive Officer, Director
Offering amount
$5M
Amount sold
$4.1M
Minimum investment
$10K
Proceeds to insiders
$750K
First sale
Jul 2024
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedNov 2023 · 32 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Eric SauterDirector
  • John R SlumpExecutive Officer, Director
  • Steven MickelsenDirector
Offering amount
$5M
Amount sold
$5M
Minimum investment
$100K
Proceeds to insiders
$1M
First sale
Feb 2023
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$400KraisedNov 2023 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John R SlumpExecutive Officer, Director
  • Eric SauterDirector
  • Steven MickelsenDirector
Offering amount
$3M
Amount sold
$400K
Minimum investment
$100K
Proceeds to insiders
$500K
First sale
Oct 2023
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Atraverse Medical went on to found or lead other companies.

In the news

Frequently asked questions

What does Atraverse Medical do?
Atraverse Medical develops flexible transseptal access technologies for left-heart catheter procedures, including an RF-guidewire enabled puncture device that supports a Zero Exchange workflow. Its products are aimed at physicians performing catheter-based cardiac interventions.
Who founded Atraverse Medical?
Atraverse Medical was founded by Steven Mickelsen in 2022.
Who are Atraverse Medical's investors?
Atraverse Medical's investors include Band of Angels, MEDA Angels.
How much funding has Atraverse Medical raised?
Atraverse Medical has disclosed $33.1M raised across 5 rounds.
Where is Atraverse Medical headquartered?
Atraverse Medical is headquartered in Chicago, US.